PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$39.34
+1.34%Forward multiples
Based on analyst estimates
- P/E forward
- 11.13x
- P/E 2026E
- 12.87x
- P/E 2027E
- 11.32x
- P/E 2028E
- 10.28x
- P/S forward
- 0.96x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.99x
- PEG TTM
- 0.37x
- Price / book
- 4.14x
- Price / sales
- 1.05x
- Price / cash flow
- 23.16x
Enterprise value
- Enterprise value
- $2.3B
- EV / sales
- 1.52x
- EV / EBITDA
- 9.74x
- EV / EBIT
- 11.61x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026